Global Vaccine Market 2018-2024
18-Jun-2018 | Number of pages: 218 | Report Id: BMRC PH 126 | Report Format: | Status: Published

Vaccines Market By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Indication (Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Hepatitis ), By End User (Pediatric Vaccines, Adult Vaccines, Traveller Vaccines), Industry Analysis, Trends, and Forecast 2018 – 2024

Vaccines Market: Rising burden of several infectious and non-infectious diseases, increasing government and non government support for vaccine development, and increasing Research and Underdevelopment likely to augment the growth of Global Vaccine Market.

Scope of Global Vaccine Market Reports –

 A vaccine is a biological preparationwhich is administered to produceactive acquired immunity for particular disease and it is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called as “Vaccination” which aids to increase the immune response against a specific pathogen.Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine uses that ability of the body to enable it to defend itself from those microorganisms which have attacked it earlier. Usually vaccines are administered through injections, orally and sprayed into the nose.Vaccines can be divides into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.

The Global Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc.The demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases. Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout lifespan and gives protection against different types of infectious diseases.Vaccine technology is procedure to observe a revolution. As a more understanding of the human immune system’s protective antibody and cell-based responses to foreign antigens will causes the development of advanced diagnostics and improvement of therapeutic applications. As further governments across the

World identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Certain increasing demand worldwide and currently-unmet needs, the Global Vaccination Market has substantial potential for technological novelty and revenue growth.Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection. The increasing popularity of pediatric, travel, addiction and pediatric combination vaccines the newly developed vaccines that are safer and more effective, better public awareness, technological advancements in molecular genetics area and the adoption of novel vaccine delivery mechanisms are chiefly driving the growth of the global vaccination market. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boost the Global Vaccine Market growth.

Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover additional 1.5 million deaths could be avoided due to enhanced global vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its global usage in the upcoming future.

Global Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of TechnologyGlobal Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines,Inactivated Vaccines Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of IndicationGlobal Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User Global Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.

The regions covered in Global Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Vaccines Market Reports –

Global Vaccines Market reports cover prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Bavarian Nordic,Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb,Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc.,Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd.,Janssen Pharmaceutical Company,Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai,Hissen andJintan.

Global Vaccines Market Dynamics –

The rise in acceptance of pediatrics, travel, addiction, and pediatric combination vaccines also recently developed vaccines that are safer and more effective, better, public awareness, technological advancements in molecular genetics area and the acceptance of new vaccine delivery mechanisms are mainly driving the growth of the Global Vaccination Market. Rise inincidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well asGovernment initiatives for expanding vaccination coverage are likely to boost the demand for vaccines globally. The Government of Asian country launched the ‘Pan-India campaign for contagious disease-Rubella Vaccination’ in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles.This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years and increasing investments by companies are driving the vaccine market.Excessive cost related with storage and transportation of vaccines will restrain the Global Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the Global Vaccine Market expansion over the coming years. Crucial problems in the Global Vaccine Market now a days are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems.

Global Vaccine Market Regional Analysis –

Geographically, North America is expected to dominate the market in terms of revenues, due to continuous research funding for vaccine development in the region, increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. Also because of launch of recent vaccine by pharmaceutical firms is predicted to assist the region maintain its dominance throughout the forecast amount. Introduction of recent product is predicted to enhance the demand for the vaccines within the region therefore serving to it stay the biggest marketplace for this product globally. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.
Europe is likely to hold the second largest share of this market due to availability of funding and venture capital investments for the development of new vaccines and increasing government initiatives driven market growth in this region.

Germany will grow at a significant rate over the coming years due to increasing government initiatives to provide medical advice for the vaccinating children. Increasing prevalence of infectious diseases and focused product development will boost the Global Vaccine Market.

Asia Pacific can see substantial growth over the forecast amount because of increasing awareness for interference of diseases like TB (TB), Japanese cephalitis, protozoal infection and dengue fever still as introduction of re-emerging or newer diseases like infection with severe acute metabolic process syndrome (SARS), respiratory disease A (H5N1) virus (avian flu) and Chikungunya. Additionally rising financial condition and growing adoption for advanced technology ought to accelerate regional revenue share.

Key Benefits for Global Vaccine Market Reports –

  • Global Vaccine Market report covers in depth historical and forecast analysis.
  • Global Vaccine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Vaccine Market report helps to identify opportunities in market place.
  • Global Vaccine Market report covers extensive analysis of emerging trends and competitive landscape.

Vaccine Market Segmentation

By Technology 

  • Conjugate Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

By Indication 

  • Influenza
  • Pneumococcal Disease
  • Meningococcal Disease
  • Human Papilloma Virus
  • Rotavirus
  • Varicella
  • Diphtheria-Pertussis-Tetanus (DTP)
  • Polio
  • Hepatitis
  • Measles-Mumps- Rubella (MMR)
  • Others

By End User 

  • Pediatric Vaccines
  • Adult Vaccines
  • Traveller Vaccines
  • Others

By Region

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Coronary Stents Market Key Players

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Johnson & Johnson
  • Medimmune
  • LLC
  • Astellas Pharma Inc.
  • Serum Institute of India

 

Global Vaccine Market 2018-2024

Our 218 pages report provides 75 tables, 83 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Vaccine Market
  • To receive forecasts of Global Vaccine Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in theGlobal Vaccine Marketsector
  • To determine the forces and factor that influences the market forGlobal Vaccine Market: drivers, restraints, opportunities and threats
  • To find out where the Global Vaccine Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Vaccine Market: By Region Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

GlobalXXXXXXXXXX
North AmericaXXXXXXXXXX
EuropeXXXXXXXXXX
Asia PacificXXXXXXXXXX
Latin AmericaXXXXXXXXXX
Middle East & AfricaXXXXXXXXXX
GlobalXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Vaccine Market: By Technology Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Conjugate VaccinesXXXXXXXXXX
Inactivated VaccinesXXXXXXXXXX
Live Attenuated VaccinesXXXXXXXXXX
Toxoid VaccinesXXXXXXXXXX
Recombinant Vaccines XXXXXXXXXX
OthersXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Vaccine Market: By Indication Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

InfluenzaXXXXXXXXXX
Pneumococcal DiseaseXXXXXXXXXX
Meningococcal DiseaseXXXXXXXXXX
Human Papilloma VirusXXXXXXXXXX
RotavirusXXXXXXXXXX
VaricellaXXXXXXXXXX
Diphtheria-Pertussis-Tetanus (DTP)XXXXXXXXXX
PolioXXXXXXXXXX
HepatitisXXXXXXXXXX
Measles-Mumps- Rubella (MMR)

 

XXXXXXXXXX
OthersXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Vaccine Market: By End User Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Pediatric VaccinesXXXXXXXXXX
Adult VaccinesXXXXXXXXXX
Traveller Vaccines XXXXXXXXXX
OthersXXXXXXXXXX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey ofGlobal Vaccine Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

 Companies Mentioned in This Report,

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Johnson & Johnson
  • Medimmune
  • LLC
  • Astellas Pharma Inc.
  • Serum Institute of India
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company Limited
  • Bavarian Nordic
  • Panacea Biotech
  • Protein Sciences Corporation
  • AstraZeneca
  • Abbott
  • Bristol-Myers Squibb
  • Novavax Inc.
  • Gritstone Oncology
  • PaxVax Corporation
  • Bharat Biotech
  • VBI Vaccines Inc.
  • Dynavax Technologies Corporation
  • Immunomic Therapeutics Inc.
  • Gamma Vaccines Pty Limited
  • Sinovac Biotech Ltd.
  • Prokarium and ImmunoBiology Ltd.
  • Janssen Pharmaceutical Company
  • Takeda Pharmaceuticals Company Ltd.
  • Valeant Pharmaceuticals International Inc.
  • China National Biotech
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan
  • Others

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Vaccines Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Vaccines Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Vaccines Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  3. Chapter – Global Vaccines Market Overview: Quantitative Analysis
    • Global Vaccines Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Vaccines Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  4. Chapter – 3.2. Global Vaccines Market: by Technology
  5. Chapter – 3.2. Global Vaccines Market: by Indication
  6. Chapter -3.2. Global Vaccines Market: by End User
  • Global Vaccines Market (USD Million), by Manufacturer, 2014 – 2024
  • Global Vaccines Market Production (K Unit), by Manufacturer, 2014 – 2024
  • Global Vaccines Market Consumption (K Unit), Manufacturer, 2014 – 2024
  • Global Vaccines Market Share (%), by Manufacturer, 2017
  • Global Vaccines Market Price (USD/Unit), by Manufacturer, 2014 – 2024
  • Global Vaccines Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
  • Merger & Acquisition
  • Collaborations and Partnership
  • New Product Launch
  1. Chapter – Global Vaccines Market : Regional Analysis
    • North America
    • North America Global Vaccines Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Vaccines Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Vaccines Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  2. Chapter – Company Profiles
    • GlaxoSmithKline plc
    • Overview
    • Financials
    • Product portfolio
  • Global Vaccines Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
  • Global Vaccines Market Share (%), 2014 – 2017
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Sanofi
    • CSL Limited
    • Emergent BioSolutions Inc.
    • Johnson & Johnson
    • Medimmune
    • LLC
    • Astellas Pharma Inc.
    • Serum Institute of India
    • Bavarian Nordic
    • Mitsubishi Tanabe Pharma Corporation
    • Daiichi Sankyo Company Limited
    • Bavarian Nordic
    • Panacea Biotech
    • Protein Sciences Corporation
    • AstraZeneca
    • Abbott
    • Bristol-Myers Squibb
    • Novavax Inc.
    • Gritstone Oncology
    • PaxVax Corporation
    • Bharat Biotech
    • VBI Vaccines Inc.
    • Dynavax Technologies Corporation
    • Immunomic Therapeutics Inc.
    • Gamma Vaccines Pty Limited
    • Sinovac Biotech Ltd.
    • Prokarium and ImmunoBiology Ltd.
    • Janssen Pharmaceutical Company
    • Takeda Pharmaceuticals Company Ltd.
    • Valeant Pharmaceuticals International Inc.
    • China National Biotech
    • Tiantan
    • Hualan
    • Kangtai
    • Hissen
    • Jintan
    • Others

 

  1. Chapter – Market Research and Findings

 

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Johnson & Johnson
  • Medimmune
  • LLC
  • Astellas Pharma Inc.
  • Serum Institute of India
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company Limited
  • Bavarian Nordic
  • Panacea Biotech
  • Protein Sciences Corporation
  • AstraZeneca
  • Abbott
  • Bristol-Myers Squibb
  • Novavax Inc.
  • Gritstone Oncology
  • PaxVax Corporation
  • Bharat Biotech
  • VBI Vaccines Inc.
  • Dynavax Technologies Corporation
  • Immunomic Therapeutics Inc.
  • Gamma Vaccines Pty Limited
  • Sinovac Biotech Ltd.
  • Prokarium and ImmunoBiology Ltd.
  • Janssen Pharmaceutical Company
  • Takeda Pharmaceuticals Company Ltd.
  • Valeant Pharmaceuticals International Inc.
  • China National Biotech
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan
  • Others